Tremfya 100 MG/ML one-pressml
Ended Awarded
- Contract number
- SPE2DB25FAVVS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,211
Award facts
- Contract value 100% obligated
- $21,210.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $21,210.57 by the Defense Logistics Agency on July 25, 2025. The contract calls for the delivery of TREMFYA 100 MG/ML, a prescription injectable medication used in the treatment of psoriasis and psoriatic arthritis, with an ultimate completion date of July 28, 2025. The contract does not utilize a set-aside designation, and performance is to be completed in Conshohocken, Pennsylvania.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare facilities worldwide. The IDC covers branded and generic prescription drugs, biologics, and medical consumables across multiple product categories. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency to provide direct distribution of medications and pharmacy services to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FAVVS?
SPE2DB25FAVVS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 25, 2025.
How much is contract SPE2DB25FAVVS worth?
The government has obligated $21,211 on SPE2DB25FAVVS.
Is contract SPE2DB25FAVVS an order under another contract?
Yes. SPE2DB25FAVVS is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVVS competed?
The extent of competition for SPE2DB25FAVVS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award